Israeli - Kiebrania - Ministry of Health

pfizer pharmaceuticals israel ltd - covid-19 mrna vaccine - covid-19 mrna vaccine 0.5 mg/ml - covid-19 vaccines

Israeli - Kiebrania - Ministry of Health

medison pharma ltd - pasireotide as pamoate - אבקה וממס להכנת תרחיף להזרקה - pasireotide as pamoate 10 mg/vial - pasireotide

Israeli - Kiebrania - Ministry of Health

medison pharma ltd - pasireotide as pamoate - אבקה וממס להכנת תרחיף להזרקה - pasireotide as pamoate 30 mg/vial - pasireotide

Israeli - Kiebrania - Ministry of Health

medison pharma ltd - interferon beta 1a 30 mcg/vial - powder for solution for injection - interferon beta-1a - avonex is indicated for the treatment of relapsing forms of multiple sclerosis to slow the accumulation of physical disability and to decrease the frequency of clinical exacerbations. avonex is also indicated for the treatment of patients who have experienced a single demyelinating event with an active inflammatory process if it is severe enough to warrant treatment with intravenous corticosteroids if alternative diagnosis have been excluded, including the prescence of mri abnormalities characteristic of ms and if they are determined to be at high risk of developing clinically definite multiple sclerosis. safety and efficacy in patients with chronic progressive multiple sclerosis has not been evaluated.

Israeli - Kiebrania - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - metformin hydrochloride; sitagliptin - טבליות מצופות פילם - metformin hydrochloride 1000 mg; sitagliptin 50 mg - metformin and sitagliptin

Israeli - Kiebrania - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - metformin hydrochloride; sitagliptin - טבליות מצופות פילם - metformin hydrochloride 850 mg; sitagliptin 50 mg - metformin and sitagliptin

Israeli - Kiebrania - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - medroxyprogesterone acetate - תרחיף להזרקה - medroxyprogesterone acetate 150 mg/ml - medroxyprogesterone - medroxyprogesterone - for contraception where medically indicated and oral administration is inapplicable.

Israeli - Kiebrania - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - methylprednisolone acetate - תרחיף להזרקה - methylprednisolone acetate 40 mg/ml - methylprednisolone - methylprednisolone - for the treatment of conditions responsive to steroid injection therapy.

Israeli - Kiebrania - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - meropenem as trihydrate - אבקה להמסה להזרקה\אינפוזיה - meropenem as trihydrate 500 mg/vial - meropenem - meropenem - meropenem is indicated for treatment in adults and children of the following severe infections caused by single or multiple susceptible bacteria sensitive to meropenem: - pneumonias and nosocomial pneumonias. - pulmonary infections in patients with cystic fibrosis. - urinary tract infections. - intra-abdominal infections. - gynecological infections such as endometritis and pelvic inflammatory disease. - skin and skin structure infections. - meningitis -septicemia. meropenem has proved efficacious alone or in combination with other antimicrobial agents in the treatment of polymicrobial infections. there is no experience in pediatric patients with neutropenia or primary or secondary immunodeficiency

Israeli - Kiebrania - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - meropenem as trihydrate - אבקה להמסה להזרקה\אינפוזיה - meropenem as trihydrate 1000 mg/vial - meropenem - meropenem - meropenem is indicated for treatment in adults and children of the following severe infections caused by single or multiple susceptible bacteria sensitive to meropenem: - pneumonias and nosocomial pneumonias. - pulmonary infections in patients with cystic fibrosis. - urinary tract infections. - intra-abdominal infections. - gynecological infections such as endometritis and pelvic inflammatory disease. - skin and skin structure infections. - meningitis -septicemia. meropenem has proved efficacious alone or in combination with other antimicrobial agents in the treatment of polymicrobial infections. there is no experience in pediatric patients with neutropenia or primary or secondary immunodeficiency